184 related articles for article (PubMed ID: 24420527)
61. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
[TBL] [Abstract][Full Text] [Related]
62. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
Bruins HM; Arends TJ; Pelkman M; Hulsbergen-van de Kaa CA; van der Heijden AG; Witjes JA
Clin Genitourin Cancer; 2014 Jun; 12(3):190-5. PubMed ID: 24332508
[TBL] [Abstract][Full Text] [Related]
63. Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of age.
Novotny V; Hakenberg OW; Froehner M; Zastrow S; Leike S; Koch R; Wirth MP
Urol Int; 2013; 90(2):195-201. PubMed ID: 23363612
[TBL] [Abstract][Full Text] [Related]
64. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
65. The impact of socioeconomic status on prostate cancer treatment and survival in the southern Netherlands.
Aarts MJ; Koldewijn EL; Poortmans PM; Coebergh JW; Louwman M
Urology; 2013 Mar; 81(3):593-9. PubMed ID: 23312891
[TBL] [Abstract][Full Text] [Related]
66. Utilisation of preoperative imaging for muscle-invasive bladder cancer: a population-based study.
McInnes MD; Siemens DR; Mackillop WJ; Peng Y; Wei S; Schieda N; Booth CM
BJU Int; 2016 Mar; 117(3):430-8. PubMed ID: 25561020
[TBL] [Abstract][Full Text] [Related]
67. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results.
Mills RD; Fleischmann A; Studer UE
Surg Oncol Clin N Am; 2007 Jan; 16(1):233-45. PubMed ID: 17336246
[TBL] [Abstract][Full Text] [Related]
68. Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.
Alkhateeb SS; Van Rhijn BW; Finelli A; van der Kwast T; Evans A; Hanna S; Vajpeyi R; Fleshner NE; Jewett MA; Zlotta AR
J Urol; 2010 Jul; 184(1):81-6. PubMed ID: 20478593
[TBL] [Abstract][Full Text] [Related]
69. Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy.
Froehner M; Koch R; Hübler M; Heberling U; Novotny V; Zastrow S; Hakenberg OW; Wirth MP
BMC Urol; 2018 Oct; 18(1):91. PubMed ID: 30348141
[TBL] [Abstract][Full Text] [Related]
70. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
[TBL] [Abstract][Full Text] [Related]
71. Muscle Invasive Bladder Cancer (MIBC) - The Gold Standard Radical Cystectomy or Bladder Preserving Approach, YES or NO?
Mahmud SM
J Pak Med Assoc; 2018 Oct; 68(10):1425-1426. PubMed ID: 30317334
[No Abstract] [Full Text] [Related]
72. Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes.
Steffensen EH; Cary C; Jensen JB; Larsson H; Weiner M; Nørgaard M
BMC Cancer; 2018 Oct; 18(1):1035. PubMed ID: 30355276
[TBL] [Abstract][Full Text] [Related]
73. Prognosis of patients with muscle invasive bladder cancer who are intolerable to receive any anti-cancer treatment.
Ogawa K; Shimizu Y; Uketa S; Utsunomiya N; Kanamaru S
Cancer Treat Res Commun; 2020; 24():100195. PubMed ID: 32688293
[TBL] [Abstract][Full Text] [Related]
74. Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival.
Kollberg P; Chebil G; Eriksson P; Sjödahl G; Liedberg F
Urol Oncol; 2019 Oct; 37(10):791-799. PubMed ID: 31056435
[TBL] [Abstract][Full Text] [Related]
75. Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer.
Solanki AA; Martin B; Korpics M; Small C; Harkenrider MM; Mitin T
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):429-435. PubMed ID: 28242163
[TBL] [Abstract][Full Text] [Related]
76. Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer.
Ripping TM; Witjes JA; Meijer RP; van Rhijn BWG; Oddens JR; Goossens-Laan CA; Mulder SF; van Moorselaar RJA; Kiemeney LA; Aben KKH
Urol Oncol; 2020 Dec; 38(12):935.e9-935.e16. PubMed ID: 32917503
[TBL] [Abstract][Full Text] [Related]
77. Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy.
Froehner M; Koch R; Heberling U; Borkowetz A; Hübler M; Novotny V; Wirth MP; Thomas C
Urol Int; 2020; 104(7-8):567-572. PubMed ID: 32541139
[TBL] [Abstract][Full Text] [Related]
78. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.
Fonteyne V; Ost P; Bellmunt J; Droz JP; Mongiat-Artus P; Inman B; Paillaud E; Saad F; Ploussard G
Eur Urol; 2018 Jan; 73(1):40-50. PubMed ID: 28478043
[TBL] [Abstract][Full Text] [Related]
79. Significance of age and comorbidity as prognostic indicators for patients with bladder cancer.
Ha MS; Chang IH
Asian J Androl; 2010 Sep; 12(5):766-74. PubMed ID: 20676116
[TBL] [Abstract][Full Text] [Related]
80. Associations Between Female Sex and Treatment Patterns and Outcomes for Muscle-invasive Bladder Cancer.
Grajales V; Bandari J; Hale NE; Yabes JG; Turner RM; Fam MM; Sabik LM; Gingrich JR; Davies BJ; Jacobs BL
Urology; 2021 May; 151():169-175. PubMed ID: 32673679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
